WALLENIUS WILHELMS And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – WALLENIUS WILHELMS (WAWI.OL), BE SEMICONDUCTOR (BESI.AS), SPAREBANK 1 SMN (MING.OL) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. WALLENIUS WILHELMS (WAWI.OL)

1027.3% sales growth and 30.36% return on equity

Wallenius Wilhelmsen ASA, together with its subsidiaries, engages in the logistics and transportation business worldwide. It operates through three segments: Shipping Services, Logistics Services, and Government Services. The company provides liner services through a fleet of modern and versatile RoRo vessels, which carry a mix of products, such as auto, construction, mining, agriculture machinery, and breakbulk products. In addition, it offers inland transportation services, as well as operates vehicle and equipment processing centers and inland distribution networks. The company serves agriculture, automotive, aviation, boats and yachts, breakbulk, commercial vehicles, construction, machinery and machine tools, mining, oil and gas, power and energy, and rail industries. It operates approximately 125 vessels servicing 15 trade routes, 66 processing centers, and 8 marine terminals. Wallenius Wilhelmsen ASA was founded in 1861 and is based in Lysaker, Norway.

Earnings Per Share

As for profitability, WALLENIUS WILHELMS has a trailing twelve months EPS of kr22.62.

PE Ratio

WALLENIUS WILHELMS has a trailing twelve months price to earnings ratio of 5.78. Meaning, the purchaser of the share is investing kr5.78 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.36%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 4.4%, now sitting on 5.21B for the twelve trailing months.

Volume

Today’s last reported volume for WALLENIUS WILHELMS is 367426 which is 31.33% below its average volume of 535088.

Moving Average

WALLENIUS WILHELMS’s worth is way higher than its 50-day moving average of kr107.43 and way higher than its 200-day moving average of kr102.66.

Yearly Top and Bottom Value

WALLENIUS WILHELMS’s stock is valued at kr130.70 at 06:20 EST, below its 52-week high of kr138.60 and way above its 52-week low of kr81.55.

More news about WALLENIUS WILHELMS.

2. BE SEMICONDUCTOR (BESI.AS)

49.4% sales growth and 40.81% return on equity

BE Semiconductor Industries N.V. engages in the development, manufacture, marketing, sale, and service of semiconductor assembly equipment for the semiconductor and electronics industries in China, the United States, Malaysia, Ireland, Korea, Taiwan, Thailand, Other Asia Pacific and Europe, and internationally. It operates through three segments: Die Attach, Packaging, and Plating. The company's principal products include die attach equipment, such as single chip, multi-chip, multi module, flip chip, thermal compression bonding, fan out wafer level packaging, hybrid and embedded bridge die bonding, and die sorting systems; and packaging equipment, including conventional, ultra-thin, and wafer level molding, as well as trim and form, and singulation systems. It also provides plating equipment, such as tin, copper, and precious metal and solar plating systems, as well as related process chemicals; and tooling, conversion kits, spare parts, and other services. The company's principal brand names include Datacon, Esec, Fico, and Meco. It offers its products primarily to multinational chip manufacturers, assembly subcontractors, and electronics and industrial companies. BE Semiconductor Industries N.V. was incorporated in 1995 and is headquartered in Duiven, the Netherlands.

Earnings Per Share

As for profitability, BE SEMICONDUCTOR has a trailing twelve months EPS of €2.11.

PE Ratio

BE SEMICONDUCTOR has a trailing twelve months price to earnings ratio of 48.32. Meaning, the purchaser of the share is investing €48.32 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 40.81%.

More news about BE SEMICONDUCTOR.

3. SPAREBANK 1 SMN (MING.OL)

14.4% sales growth and 14.9% return on equity

SpareBank 1 SMN, together with its subsidiaries, provides various banking, accounting, and real estate products and services to private individuals and companies in Norway and internationally. The company offers mortgage, vehicle, green, move, consumer and other loans; refinancing; and placement, group, savings, business, group, tax deduction, currency, and deposit accounts. It also provides BSU house savings for young people; fixed interest deposits; savings and investments; cash services; and payments. In addition, the company offers car, home, personal, animal, vehicle, and travel insurance services; property buying and selling advisory services; and mobile and online banking, and various cards. Further, it offers loans for car, vehicles, and trailers, bank guarantees, business and construction loans, operating credit for agriculture, factoring, leasing, and overdrafts; various pension products; and business and personal insurance products. Additionally, the company provides documentary collection, letter of credit, forward contracts, and foreign currency account services; and accounting, HR services, taxes and duties, transactional advice, and IT solutions services. It offers money transfer, capital and investment management, advisory, interest rate and currency hedging, and investment of surplus liquidity services. SpareBank 1 SMN was founded in 1823 and is headquartered in Trondheim, Norway.

Earnings Per Share

As for profitability, SPAREBANK 1 SMN has a trailing twelve months EPS of kr17.98.

PE Ratio

SPAREBANK 1 SMN has a trailing twelve months price to earnings ratio of 9.01. Meaning, the purchaser of the share is investing kr9.01 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.9%.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Mar 22, 2024, the estimated forward annual dividend rate is 12 and the estimated forward annual dividend yield is 7.77%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 19.3%, now sitting on 8.38B for the twelve trailing months.

Moving Average

SPAREBANK 1 SMN’s worth is above its 50-day moving average of kr154.17 and higher than its 200-day moving average of kr148.59.

Sales Growth

SPAREBANK 1 SMN’s sales growth is 18.1% for the current quarter and 14.4% for the next.

More news about SPAREBANK 1 SMN.

4. PERNOD RICARD (RI.PA)

7.9% sales growth and 9.04% return on equity

Pernod Ricard SA produces and sells wines and spirits worldwide. The company offers whiskey, vodka, gin, rum, liqueur and bitters, champagne, tequila and mezcal, and aperitif under the brands 100 Pipers, Aberlour, Absolut, Absolut Elyx, Altos, ARARAT, Augier, Avion, Ballantine's, Becherovka, Beefeater, Blenders Pride, Brancott Estate, Campo Viejo, Ceder's, Chivas, Church Road, Clan Campbell, Del Maguey, George Wyndham, Green Spot, Havana Club, Imperial, Imperial Blue, Italicus, J.P. Wiser's, Jacob's Creek, Jameson, Jefferson's, Kahlúa, Kenwood, KI NO BI, Lillet, Long John, L'Orbe, Lot No. 40, Malfy, Malibu, Martell, Method & Madness, Midleton Very Rare, Minttu, Monkey 47, Mumm, Olmeca, Ostoya, Passport Scotch, Pastis 51, Pernod, Perrier-Jouët, Plymouth Gin, Powers, Rabbit Hole, Ramazzotti, Redbreast, Ricard, Royal Salute, Royal Stag, Scapa, Seagram's Gin, Secret Speyside, Smooth Ambler, Something Special, St Hugo, Stoneleigh, Suze, The Glenlivet, TX, Wyborowa, and Ysios. It also provides non-alcoholic beverages under the brands Ceder's, Suze Tonic 0%, Cinzano Spritz 0%, Pacific, Campo Viejo Sparkling 0%, and Jacob's Creek Unvined. Pernod Ricard SA was founded in 1805 and is headquartered in Paris, France.

Earnings Per Share

As for profitability, PERNOD RICARD has a trailing twelve months EPS of €8.04.

PE Ratio

PERNOD RICARD has a trailing twelve months price to earnings ratio of 18.65. Meaning, the purchaser of the share is investing €18.65 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.04%.

Moving Average

PERNOD RICARD’s worth is way above its 50-day moving average of €127.37 and higher than its 200-day moving average of €138.27.

More news about PERNOD RICARD.

5. SANOFI (SAN.PA)

7.4% sales growth and 5.82% return on equity

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Earnings Per Share

As for profitability, SANOFI has a trailing twelve months EPS of €4.3.

PE Ratio

SANOFI has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.82%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on May 13, 2024, the estimated forward annual dividend rate is 3.76 and the estimated forward annual dividend yield is 3.73%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 5.2% and positive 0.8% for the next.

Yearly Top and Bottom Value

SANOFI’s stock is valued at €90.96 at 06:20 EST, way under its 52-week high of €106.14 and way above its 52-week low of €80.60.

More news about SANOFI.

6. SPBK1 ØSTFOLD AKE (SOAG.OL)

7.3% sales growth and 12.1% return on equity

SpareBank 1 Østfold Akershus, a savings bank, provides various banking products and services. The company offers savings, operating, tax deduction, deposit, placement, and currency accounts; and savings and investment products. It also provides consumer, construction, repayment, boat, motorcycle, and car loans; operating credit products; bank guarantees; operating credit for agriculture; mortgage products; leasing and factoring services. In addition, the company offers various insurance products, such as vehicle, house and travel, personal, animal, liability, work machine, interruption, condominium, cyber, movable property, commercial building, project, transport, crime, bus, group life, health, leisure accident, occupational injury, accident insurance children, and sick pay insurance products; and pension products. Further, it provides credit, municipal payment, and other bank cards; payment terminal, debt collection, and document collection services; bonds, forwards, and currency options; invoice automatic, eGiro/Cremul, KID invoice, and OCR and eGiro payment services; and mobile and online banking services. SpareBank 1 Østfold Akershus was founded in 1835 and is headquartered in Moss, Norway.

Earnings Per Share

As for profitability, SPBK1 ØSTFOLD AKE has a trailing twelve months EPS of kr38.29.

PE Ratio

SPBK1 ØSTFOLD AKE has a trailing twelve months price to earnings ratio of 9.66. Meaning, the purchaser of the share is investing kr9.66 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.1%.

Yearly Top and Bottom Value

SPBK1 ØSTFOLD AKE’s stock is valued at kr369.90 at 06:20 EST, above its 52-week high of kr343.00.

More news about SPBK1 ØSTFOLD AKE.

Leave a Reply

Your email address will not be published. Required fields are marked *